Phase 3 Data on VIVUS' Avanafil for Erectile Dysfunction to be Featured at the AUA 2010 Annual Meeting, "[1]" http://www.prnewswire.com/news-releases/phase-3-data-on-vivus-avanafil-for-erectile-dysfunction-to-be-featured-at-the-aua-2010-annual-meeting-95098154.html
"Most Popular in Your Life". USA Today. http://yourlife.usatoday.com/health/healthyperspective/post/2012-04-27/fda-approves-new-drug-for-erectile-dysfunction/682550/1?csp=34news
"VIVUS and Auxilium Announce Stendra Label Expansion". Zacks Investment Research. https://www.zacks.com/stock/news/147893/vivus-and-auxilium-announce-stendra-label-expansion
Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP), "[2][permanent dead link]" http://www.vivus.com/images/stories/downloads_newsroom/equipobesityoct2011.pdf
Hellmich, Nancy (17 July 2012). "New diet drug helps patients lose about 10% of weight". USA Today. Retrieved 17 July 2012. https://www.usatoday.com/news/health/story/2012-07-18/qsymia-diet-drug-approval/56271594/1
"Medications Target Long-Term Weight Control". FDA.gov. Retrieved 17 July 2012. https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm312380.htm
"2016 Winners by rank" (PDF). Deloitte. Archived from the original (PDF) on 21 November 2016. Retrieved 14 October 2017. https://web.archive.org/web/20161121233341/https://www2.deloitte.com/content/dam/Deloitte/us/Documents/technology-media-telecommunications/us-tmt-2016-fast-500-winners-by-rank.pdf
"Drugmaker Vivus Files for Bankruptcy in Deal With IEH". The Wall Street Journal. July 7, 2020. https://www.wsj.com/articles/drugmaker-vivus-files-for-bankruptcy-in-deal-with-ieh-11594165230